Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Glioblastoma”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Early research (Phase 1)Study completedNCT03224104
What this trial is testing

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Who this might be right for
Astrocytoma, Grade IIIGlioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 71
Testing effectiveness (Phase 2)Ended earlyNCT01508117
What this trial is testing

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati 1
Not applicableNot Yet RecruitingNCT07492836
What this trial is testing

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

Who this might be right for
Glioblastoma (GBM)
Hospital do Coracao 10
Large-scale testing (Phase 3)Study completedNCT00430911
What this trial is testing

Radiotherapy for Malignant Astrocytomas in the Elderly

Who this might be right for
Primary Brain TumorAnaplastic AstrocytomaGlioblastoma Multiforme
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT01443676
What this trial is testing

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565521
What this trial is testing

UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly

Who this might be right for
Glioblastoma Multiforme, AdultGlioblastoma, IDH-mutant
Sunnybrook Health Sciences Centre 55
Not applicableStudy completedNCT05671016
What this trial is testing

Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy

Who this might be right for
Glioblastoma Multiforme, AdultRadiation ToxicityQuality of Life
Brighton and Sussex University Hospitals NHS Trust 125
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Not applicableNot Yet RecruitingNCT05641220
What this trial is testing

Biopsy Versus Resection in Elderly Glioblastoma Patients. A Prospective Cohort Study.

Who this might be right for
Glioblastoma
Erasmus Medical Center 325
Large-scale testing (Phase 3)Looking for participantsNCT05439278
What this trial is testing

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

Who this might be right for
Glioblastoma
Severance Hospital 178
Testing effectiveness (Phase 2)Ended earlyNCT00456612
What this trial is testing

Radiosurgery for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beth Israel Deaconess Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT01149850
What this trial is testing

Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Giant Cell GlioblastomaGlioblastomaGliosarcoma
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00365222
What this trial is testing

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Study completedNCT03778294
What this trial is testing

18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

Who this might be right for
GlioblastomaMalignant Glioma
Mayo Clinic 43
Large-scale testing (Phase 3)Study completedNCT01502241
What this trial is testing

Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Heidelberg University 412
Testing effectiveness (Phase 2)Study completedNCT01602588
What this trial is testing

A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)

Who this might be right for
Glioblastoma
University College, London 54
Testing effectiveness (Phase 2)Looking for participantsNCT07476794
What this trial is testing

Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma

Who this might be right for
Glioblastoma
Sunnybrook Health Sciences Centre 118
Testing effectiveness (Phase 2)Looking for participantsNCT04765514
What this trial is testing

Chemoradiotherapy Versus Chemotherapy for Elderly and Frail GBM Patients

Who this might be right for
Glioblastoma Multiforme
AHS Cancer Control Alberta 107
Not applicableWithdrawnNCT04218019
What this trial is testing

Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation

Who this might be right for
Newly Diagnosed Glioblastoma in Patients ≥70 Years
Juergen Debus
Next Page